Concourse Financial Group Securities’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5838 |
|
|
2024
Q4 | – | Sell |
-100
| Closed | -$170 | – | 6619 |
|
|
2024
Q3 | $170 | Hold |
100
| – | – | ﹤0.01% | 2191 |
|
|
2024
Q2 | $137 | Hold |
100
| – | – | ﹤0.01% | 2259 |
|
|
2024
Q1 | $375 | Hold |
100
| – | – | ﹤0.01% | 2234 |
|
|
2023
Q4 | $981 | Sell |
100
-20
| -17% | -$196 | ﹤0.01% | 2112 |
|
|
2023
Q3 | $1K | Sell |
120
-111
| -48% | -$927 | ﹤0.01% | 2097 |
|
|
2023
Q2 | $3.07K | Hold |
231
| – | – | ﹤0.01% | 1941 |
|
|
2023
Q1 | $2.67K | Sell |
231
-843
| -78% | -$9.76K | ﹤0.01% | 2002 |
|
|
2022
Q4 | $8.79K | Hold |
1,074
| – | – | ﹤0.01% | 1697 |
|
|
2022
Q3 | $6K | Hold |
1,074
| – | – | ﹤0.01% | 1613 |
|
|
2022
Q2 | $5K | Hold |
1,074
| – | – | ﹤0.01% | 1845 |
|
|
2022
Q1 | $10K | Buy |
1,074
+265
| +33% | +$2.47K | ﹤0.01% | 1691 |
|
|
2021
Q4 | $17K | Sell |
809
-1,236
| -60% | -$26K | ﹤0.01% | 1701 |
|
|
2021
Q3 | $52K | Buy |
2,045
+47
| +2% | +$1.2K | ﹤0.01% | 1283 |
|
|
2021
Q2 | $70K | Buy |
1,998
+100
| +5% | +$3.5K | ﹤0.01% | 1145 |
|
|
2021
Q1 | $63K | Buy |
1,898
+1,248
| +192% | +$41.4K | ﹤0.01% | 1127 |
|
|
2020
Q4 | $17K | Buy |
+650
| New | +$17K | ﹤0.01% | 1518 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4854 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4718 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4696 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4638 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4439 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4606 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4543 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4419 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4153 |
|